Stem Cell Therapy in Treatment of Non-communicable Diseases: Possibilities and Challenges

Main Article Content

Nahian Rahman
Mussamat Mahbuba Sultana
Marium Sultana
Susmita Ghosh
Urme Mostary
Priya Saha
Md. Ruhul Kabir


Over recent years stem cells have stood out as a promising tool for regenerative medicine, providing alternative therapeutic solutions for many non-communicable diseases. Many clinical trials using stem cells or induced pluripotent stem cells are focused on the refit and regeneration of various tissues and organs in degenerative diseases, whose current treatment only succeeds in delay down the progression of the disease. This review summarizes several current clinical and nonclinical information on the use of embryonic stem cells (ESCs), induced pluripotent stem cells (IPSCs) and mesenchymal stem cells (MSCs) in various diseases. The aim of this review was to expand on the background and therapeutic potential of ESCs, MSCs and IPSCs whilst linking this to their use within disease therapy with a specific focus on diabetes, kidney disease and cardiovascular disease with future possibilities and challenges. Also aimed to explain the benefits of transplantation with side effects shortly after transplant and later and interruptions, possibilities and challenges of transplantation.

Regenerative medicine, stem cells, stem cell therapy, pluripotent stem cells, embryonic stem cells, mesenchymal stem cells.

Article Details

How to Cite
Rahman, N., Sultana, M. M., Sultana, M., Ghosh, S., Mostary, U., Saha, P., & Kabir, M. R. (2020). Stem Cell Therapy in Treatment of Non-communicable Diseases: Possibilities and Challenges. Asian Journal of Immunology, 4(1), 10-18. Retrieved from
Review Article


Menendez JA, Joven J. Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancer, in Oxidative Stress and Inflammation in Non-communicable Diseases-Molecular Mechanisms and Perspectives in Therapeutics. Springer. 2014;117-140.

Marks PW, Witten CM, Califf RM. Clarifying stem-cell therapy’s benefits and risks. N Engl J Med. 2017;376(11):1007-1009.

Larijani B, et al. Stem cell therapy in treatment of different diseases; 2012.

Schöler HR. The potential of stem cells: An inventory, in Humanbiotechnology as social challenge. Routledge. 2016;45-72.

Ghajar CM, et al. The perivascular niche regulates breast tumour dormancy. Nature Cell Biology. 2013;15(7):807.

Ulloa-Montoya F, Verfaillie CM, Hu WS. Culture systems for pluripotent stem cells. Journal of Bioscience and Bioengineering. 2005;100(1):12-27.

Jeffrey M, Ponzetti M, David S. Stem cells an interactive qualifying project report, submitted to the faculty of worcester polytechnic institute In partial fulfillment of the requirements for the Degree of Bachelor of Science. 2006 AJPCT. 2014; 2(7):919-930.

Crispi V, Matsakas A. Duchenne muscular dystrophy: Genome editing gives new hope for treatment. Postgraduate Medical Journal, 2018;94(1111):296-304.

Alkhalil M, Smajilagic A, Redzic A. Human dental pulp mesenchymal stem cells isolation and osteoblast differentiation. Med Glas (Zenica). 2015;12(1):27-32.

Batouli S, et al. Comparison of stem-cell-mediated osteogenesis and dentinogenesis. Journal of Dental Research. 2003;82(12):976-981.

Bolós V, López Á, Aparicio LA. Cancer stem cells as a new opportunity for therapeutic intervention, in Cancer Stem Cells Theories and Practice. Intech Open; 2011.

Bangladesh Demographic and Health Survey Bangladesh: Ministry of Health and Family Welfare, Government of the People’s Republic of Bangladesh; 2014.

Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17(1):11-22.

Olson A, Graver A, Grande DA. Scaffolds for articular cartilage repair. Journal of Long-term Effects of Medical Implants. 2012;22(3).

Dulak J, et al. Adult stem cells: hopes and hypes of regenerative medicine. Acta Biochimica Polonica. 2015;62(3).

Libby P, et al. Report of the national heart, lung and blood institute-national institute of diabetes and digestive and kidney diseases working group on cardiovascular complications of type 1 diabetes mellitus. Circulation. 2005;111(25):3489-3493.

Ikarashi K, et al. Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney international. 2005;67(5):1925-1933.

Togel F, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. American Journal of Physiology-Renal Physiology. 2005;289(1):F31-F42.

Kale S, et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. The Journal of Clinical Investigation. 2003;112(1):42-49.

Hickson LJ, Eirin A, Lerman LO. Challenges and opportunities for stem cell therapy in patients with chronic kidney disease. Kidney International. 2016;89(4): 767-778.

Hauser PV, et al. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. The American Journal of Pathology. 2010;177(4):2011-2021.

van Koppen A, et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PloS One. 2012;7(6): e38746.

Janghorbani M, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. American Journal of Epidemiology. 2007;166(5):495-505.

Kelly OG, et al. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nature Biotechnology. 2011;29(8):750.

Zhang D, et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Research. 2009;19 (4):429.

Urban VS, et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells. 2008; 26(1):244-253.

Zeeshan N, et al. Journal of Cell Science & Therapy; 2017.

Terzic A, Behfar A. Regenerative heart failure therapy headed for optimization. European Heart Journal. 2014;35(19): 1231.

Min JY, et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. Journal of Applied Physiology. 2002;92(1):288-296.

Vittet D, et al. Embryonic stem cells differentiate in vitro to endothelial cells; 2011.

Bartunek J, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem cell therapy in heart fail URE) multicenter randomized trial with lineage-specified biologics. Journal of the American College of Cardiology. 2013;61 (23):2329-2338.

Nandoe Tewarie RS, et al. Stem cell-based therapies for spinal cord injury. The Journal of Spinal Cord Medicine. 2009;32 (2):105-114.

Yan L, et al. Present status and perspectives of stem cell-based therapies for gastrointestinal diseases. Stem Cell Reviews and Reports. 2009;5(3):278-282.

Meier RP, et al. Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Research. 2013; 11(3):1348-1364.

Murnaghan M, Li G, Marsh DR. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: An inhibition of angiogenesis? JBJS. 2006;88(Suppl_3): 140-147.

Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature. 2009;462(7272):433-441.

Nie T, et al. Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems. Journal of Controlled Release. 2007;122(3):287-296.

Lalwani G, et al. Tungsten disulfide nanotubes reinforced biodegradable polymers for bone tissue engineering. Acta Biomaterialia. 2013;9(9):8365-8373.

Joggerst SJ, Hatzopoulos AK. Stem cell therapy for cardiac repair: benefits and barriers. Expert Reviews in Molecular Medicine. 2009;11.

Harrison N, et al. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study. BMC Infectious Diseases. 2015;15 (1):584.

Jagasia M, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119(1):296-307.

Couriel DR, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood. 2006;107(8):3074-3080.

So EJ, Lee JS, Kim JY. Nutritional intake and nutritional status by the type of hematopoietic stem cell transplantation. Clinical Nutrition Research. 2012;1(1):3-12.

de Defranchi RLB, et al. Evolution of nutritional status in patients with autologous and allogeneic hematopoietic stem cell transplant. Supportive Care in Cancer. 2015;23(5):1341-1347.

Andersen S, et al. Implementation of an evidenced based nutrition support pathway for haematopoietic progenitor cell transplant patients. Clinical Nutrition. 2015; 34(3):536-540.

Prockmann S, et al. Evaluation of diet acceptance by patients with haematological cancer during chemotherapeutic treatment. Nutricion hospitalaria. 2015;32(2):779-784.

Nygaard GO. Cognition, disease activity and MRI changes in early multiple sclerosis; 2016.

Titomanlio L, et al. Stem cell therapy for neonatal brain injury: perspectives and challenges. Annals of Neurology. 2011; 70(5):698-712.

Neeri F. British Biomedical Bulletin; 2015.

Rota C, Morigi M, Imberti B. Stem cell therapies in kidney diseases: Progress and challenges. International Journal of Molecular Sciences. 2019;20(11):2790.